Worth reading
47Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
85
¥ million (year-on-year increase in operating profit)Wording
Conditional
How definitive the wording is.Contents of this document
Supplementary materials to the earnings summaryQ3 FY20265 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥3,063 million+3.3%
Operating profit¥205 million+70.9%
Net income114 Millions of yen +50.2%profit attributable to owners of the parent
Results for the three months of the current quarter
DetailsProfit for the quarter (3Q) was ¥109 million, compared with ¥50 million in the same period of the previous year. Profit for the period (3Q) attributable to owners of the parent was ¥114 million, compared with ¥55 million in the same period of the previous year.
Full-year earnings forecast
Revenue
¥3,950 million
Operating profit
¥195 million
Profit before tax
¥200 million
Profit for the period attributable to owners of the parent
¥129 million
Progress against full-year forecast 通期の予想に対して、いまどこまで進んだかの割合です。
Revenue77.6%
Operating profit105.6%
Profit before tax100.6%
Profit for the quarter (3Q)87.6%
Profit attributable to owners of the parent (3Q)88.8%
What the company explained in this material
Breakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
RevenuePhysician career support: +¥141 million; physician professional activity support: △¥5 million; other: △¥36 million
Profit before taxRevenue: +¥99 million; personnel expenses: △¥35 million; commissions and subcontracting expenses: +¥10 million; advertising expenses: +¥10 million; allowance for doubtful accounts: △¥8 million; financial income and expenses: △¥5 million; other: +¥6 million
New initiatives
- Investment in building the membership base
- Active investment in overseas businesses
Key KPIsA metric the company considers important as a management benchmark.
- Revenue from physician career supportUp 6.6% year on yearYear on year against the same period last yearUp 6.6%
- Revenue from physician professional activity supportDown 1.7% year on yearYear on year against the same period last yearDown 1.7% year on year
- Revenue from other (medical infrastructure support)Down 7.3% year on yearYear on year against the same period last yearDown 7.3%
- Revenue growth since before the COVID-19 pandemic (2020)47.8 %
Segment results
Physician value creation servicesRevenue composition: 84.9%. Physician career support increased 5.5% year on year, while physician professional activity support accounted for 10.6% of revenue
Other (medical infrastructure support)Revenue declined 7.3% year on year. Revenue composition: 15.1%
Acquisition of treasury shares
¥38 million cash paid for purchases of treasury shares
| Item | Details |
|---|---|
| Document type | Supplementary materials to the earnings summary |
| Fiscal Period Covered | Q3 FY2026 |
| Net Sales | ¥3,063 million (YoY +3.3%) |
| Operating profit | ¥205 million (YoY +70.9%) |
| Net income | 114 Millions of yen (profit attributable to owners of the parent) (YoY +50.2%) |
| Results for the three months of the current quarter | Details Profit for the quarter (3Q) was ¥109 million, compared with ¥50 million in the same period of the previous year. Profit for the period (3Q) attributable to owners of the parent was ¥114 million, compared with ¥55 million in the same period of the previous year. |
| Full-year earnings forecast | Revenue ¥3,950 million / Operating profit ¥195 million / Profit before tax ¥200 million / Profit for the period attributable to owners of the parent ¥129 million |
| Progress against full-year forecast | Revenue 77.6% / Operating profit 105.6% / Profit before tax 100.6% / Profit for the quarter (3Q) 87.6% / Profit attributable to owners of the parent (3Q) 88.8% |
| Segment results | Physician value creation services Revenue composition: 84.9%. Physician career support increased 5.5% year on year, while physician professional activity support accounted for 10.6% of revenue / Other (medical infrastructure support) Revenue declined 7.3% year on year. Revenue composition: 15.1% |
| Breakdown of Factors Affecting the Change | Revenue Physician career support: +¥141 million; physician professional activity support: △¥5 million; other: △¥36 million / Profit before tax Revenue: +¥99 million; personnel expenses: △¥35 million; commissions and subcontracting expenses: +¥10 million; advertising expenses: +¥10 million; allowance for doubtful accounts: △¥8 million; financial income and expenses: △¥5 million; other: +¥6 million |
| Key KPIs | Indicator name Revenue from physician career support / Value Up 6.6% year on year / Year on year against the same period last year Up 6.6%, Indicator name Revenue from physician professional activity support / Value Down 1.7% year on year / Year on year against the same period last year Down 1.7% year on year, Indicator name Revenue from other (medical infrastructure support) / Value Down 7.3% year on year / Year on year against the same period last year Down 7.3%, Indicator name Revenue growth since before the COVID-19 pandemic (2020) / Value 47.8 % / Year on year against the same period last year Not disclosed |
| Acquisition of treasury shares | Amount ¥38 million (cash paid for purchases of treasury shares) / Period Not disclosed / Number of Shares Not disclosed |
| New initiatives | Investment in building the membership base, Active investment in overseas businesses |
Items this document does not state (18)
Ordinary incomeGross Profit MarginOperating profit marginSelling, general and administrative expensesSelf-assessment against the planUnit price and quantity metricsNumber of stores and locationsNumber of employeesAssumptions Underlying the Business OutlookRisk amount incorporated into the outlookMedium-term management plan targetsFinancial targetsAnnual DividendPayout ratioCapital expendituresOrders received and order backlogMarket Size / ShareKey points of the Q&A
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Higher revenue from physician career support due to an increase in full-time physician placements, lower costs for establishing a BPO center for local governments, and reductions in operating expenses, including promotional expenses for PR services and other activities.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.